Apogee 发表于 2025-3-25 06:26:57

http://reply.papertrans.cn/1/47/4675/4675-21.png

幼儿 发表于 2025-3-25 11:13:41

http://reply.papertrans.cn/1/47/4675/4675-22.png

ECG769 发表于 2025-3-25 13:25:44

Submitted on: 28 September 2010.
Revised on: 06 December 2010.
Accepted on: 01 January 2011.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

流眼泪 发表于 2025-3-25 18:23:38

http://reply.papertrans.cn/1/47/4675/4675-24.png

联邦 发表于 2025-3-25 23:43:48

Submitted on: 17 August 2016.
Revised on: 08 December 2016.
Accepted on: 30 January 2017.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

Melatonin 发表于 2025-3-26 01:51:41

http://reply.papertrans.cn/1/47/4675/4675-26.png

描绘 发表于 2025-3-26 05:49:39

http://reply.papertrans.cn/1/47/4675/4675-27.png

delta-waves 发表于 2025-3-26 10:35:14

Submitted on: 22 March 2015.
Revised on: 22 May 2015.
Accepted on: 08 June 2015.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

哀求 发表于 2025-3-26 16:38:10

Submitted on: 07 June 2008.
Revised on: 28 July 2008.
Accepted on: 15 September 2008.

___________________CANCER CHEMOTHERAPY AND PHARMACOLOGY

artless 发表于 2025-3-26 17:40:34

http://reply.papertrans.cn/1/47/4675/4675-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊CANCER CHEMOTHERAPY AND PHARMACOLOGY 2024/2025影响因子:2.771 (CANCER CHEMOTH PHARM) (0344-5704). (PHARMACOLOGY & PHAR